Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00709865 · ClinicalTrials.gov registry record · Phase 3
Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
A Phase 3 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 3
- Development phase
- 420
- Enrollment target
NCT00709865 is a Phase 3 study that has completed, run by Biogen. The registered enrollment target is 420 participants.
The verdict
NCT00709865, a Phase 3 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 420 participants
- Enrollment target
Study Summary
The purpose of the current study is to assess the safety and tolerability of intravenous tonapofylline.
Interventions
- DRUG Placebo
- DRUG tonapofylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2008-07-31 |
| Est. Completion | 2009-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00709865
The ClinicalTrials.gov registry entry for NCT00709865 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00709865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00709865 about?
NCT00709865 is a clinical study titled "Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency". The purpose of the current study is to assess the safety and tolerability of intravenous tonapofylline.
What is the current status of trial NCT00709865?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 420 participants. The study started on 2008-07-31. Estimated completion is 2009-12-31.
What interventions are being tested in trial NCT00709865?
The interventions under investigation include: Placebo (DRUG), tonapofylline (DRUG).
Who is sponsoring clinical trial NCT00709865?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.